American Heart Journal
Volume 151, Issue 5 , Pages 999-1005 , May 2006

How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure: Results from the Breathing Not Properly Multinational Study

  • Lori B. Daniels, MD

      Affiliations

    • University of California at San Diego, San Diego, CA
    • Veterans Affairs Medical Center, San Diego, CA
  • ,
  • Paul Clopton, MS

      Affiliations

    • University of California at San Diego, San Diego, CA
    • Veterans Affairs Medical Center, San Diego, CA
  • ,
  • Vikas Bhalla, MD

      Affiliations

    • University of California at San Diego, San Diego, CA
    • Veterans Affairs Medical Center, San Diego, CA
  • ,
  • Padma Krishnaswamy, MD

      Affiliations

    • University of California at San Diego, San Diego, CA
    • Veterans Affairs Medical Center, San Diego, CA
  • ,
  • Richard M. Nowak, MD, MBA

      Affiliations

    • Henry Ford Hospital, Detroit, MI
  • ,
  • James McCord, MD

      Affiliations

    • Henry Ford Hospital, Detroit, MI
  • ,
  • Judd E. Hollander, MD

      Affiliations

    • University of Pennsylvania, Pennsylvania, PA
  • ,
  • Philippe Duc, MD

      Affiliations

    • Hôpital Bichat, Paris, France
  • ,
  • Torbjørn Omland, MD, PhD

      Affiliations

    • Akershus University Hospital, University of Oslo, Norway
  • ,
  • Alan B. Storrow, MD

      Affiliations

    • University of Cincinnati College of Medicine, Cincinnati, OH
  • ,
  • William T. Abraham, MD

      Affiliations

    • Ohio State University Hospital, Columbus, OH
  • ,
  • Alan H.B. Wu, PhD

      Affiliations

    • Hartford Hospital, Hartford, CT
  • ,
  • Philippe G. Steg, MD

      Affiliations

    • Hôpital Bichat, Paris, France
  • ,
  • Arne Westheim, MD, PhD, MPH

      Affiliations

    • Akershus University Hospital, University of Oslo, Norway
  • ,
  • Cathrine Wold Knudsen, MD

      Affiliations

    • Akershus University Hospital, University of Oslo, Norway
  • ,
  • Alberto Perez, MD

      Affiliations

    • Hartford Hospital, Hartford, CT
  • ,
  • Radmila Kazanegra, MD

      Affiliations

    • University of California at San Diego, San Diego, CA
    • Veterans Affairs Medical Center, San Diego, CA
  • ,
  • Howard C. Herrmann, MD

      Affiliations

    • University of Pennsylvania, Pennsylvania, PA
  • ,
  • Peter A. McCullough, MD, MPH

      Affiliations

    • University of Missouri–Kansas City School of Medicine, Truman Medical Center, Kansas City, KS
  • ,
  • Alan S. Maisel, MD

      Affiliations

    • University of California at San Diego, San Diego, CA
    • Veterans Affairs Medical Center, San Diego, CA
    • Corresponding Author InformationReprint requests: Alan Maisel, MD, VAMC Cardiology 111-A, 3350 La Jolla Village Drive, San Diego, CA 92161.

Received 19 April 2005 ,Accepted 20 October 2005.

References 

  1. American Heart Association . Heart disease and stroke statistics—2004 update. Dallas (TX): American Heart Association; 2003;
  2. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–313
  3. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321:225–236
  4. Chen YT, Vaccarino V, Williams CS, et al. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med. 1999;106:605–612
  5. He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161:996–1002
  6. Wilhelmsen L, Rosengren A, Eriksson H, et al. Heart failure in the general population of men-morbidity, risk factors and prognosis. J Intern Med. 2001;249:253–261
  7. Alpert MA, Terry BE, Mulekar M, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol. 1997;80:736–740
  8. Alpert MA, Lambert CR, Terry BE, et al. Interrelationship of left ventricular mass, systolic function and diastolic filling in normotensive morbidly obese patients. Int J Obes Relat Metab Disord. 1995;19:550–557
  9. Alpert MA, Lambert CR, Terry BE, et al. Effect of weight loss on left ventricular mass in nonhypertensive morbidly obese patients. Am J Cardiol. 1994;73:918–921
  10. Garavaglia GE, Messerli FH, Nunez BD, et al. Myocardial contractility and left ventricular function in obese patients with essential hypertension. Am J Cardiol. 1988;62:594–597
  11. Lavie CJ, Milani RV. Obesity and cardiovascular disease: the Hippocrates paradox?. J Am Coll Cardiol. 2003;42:677–679
  12. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–977
  13. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990;322:882–889
  14. Manson JE, Bassuk SS. Obesity in the United States: a fresh look at its high toll. JAMA. 2003;289:229–230
  15. Anonymous . Getting a handle on obesity. Lancet. 2002;359:1955
  16. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–167
  17. Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594–600
  18. Dessi-Fulgheri P, Sarzani R, Tamburrini P, et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens. 1997;15:1695–1699
  19. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)–IV substudy. Circulation. 2003;108:275–281
  20. Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004;43:1590–1595
  21. McCord J, Mundy BJ, Hudson MP, et al. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med. 2004;164:2247–2252
  22. Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39:202–209
  23. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med. 2001;39:571–588
  24. Maisel A, Hollander JE, Guss D, et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol. 2004;44:1328–1333
  25. Savage DD, Garrison RJ, Kannel WB, et al. Considerations in the use of echocardiography in epidemiology. The Framingham Study. Hypertension. 1987;9:II40–II44
  26. Dessi-Fulgheri P, Sarzani R, Rappelli A. Role of the natriuretic peptide system in lipogenesis/lipolysis. Nutr Metab Cardiovasc Dis. 2003;13:244–249
  27. Sengenes C, Berlan M, De Glisezinski I, et al. Natriuretic peptides: a new lipolytic pathway in human adipocytes. Faseb J. 2000;14:1345–1351
  28. Sengenes C, Moro C, Galitzky J, et al. Natriuretic peptides: a new lipolytic pathway in human fat cells, Med Sci (Paris). 2005;21:61–65

 Triage devices and meters and some financial support were provided by Biosite, San Diego, CA. Drs Nowak, Hollander, McCullough, and Maisel, and P Clopton have served as consultants and received research support from Biosite.

PII: S0002-8703(05)00948-8

doi: 10.1016/j.ahj.2005.10.011

American Heart Journal
Volume 151, Issue 5 , Pages 999-1005 , May 2006